Related Experiment Video
Updated: Jul 18, 2025
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.0K
Challenges in developing Geroscience trials.
Yves Rolland1,2, Felipe Sierra3, Luigi Ferrucci4
1Gérontopôle de Toulouse, IHU HealthAge, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, Toulouse, France. rolland.y@chu-toulouse.fr.
Nature Communications
|August 19, 2023
Summary
Geroscience aims to prevent age-related diseases by targeting aging mechanisms. This article outlines key challenges and recommendations for designing future human aging clinical studies.
Area of Science:
- Geroscience and aging research.
- Biomedical and clinical gerontology.
Background:
- Geroscience offers a new approach to prevent age-related diseases and functional decline by targeting fundamental aging processes.
- This paradigm shift necessitates optimized clinical study designs for human aging research.
Purpose of the Study:
- To report the main results from a Geroscience expert Task Force.
- To address challenges in designing human aging clinical trials.
Main Methods:
- Expert Task Force convenes to discuss Geroscience clinical study design.
- Identification of key challenges and considerations for aging research.
Main Results:
- Challenges include defining study populations, selecting lifestyle and Gerotherapeutic interventions, and choosing primary/secondary outcomes.
- Valuable age-related biomarkers for intervention selection and response monitoring ('Gerodiagnostics') were discussed.
Conclusions:
- Optimizing clinical study design is crucial for advancing Geroscience.
- Standardizing approaches to interventions, outcomes, and Gerodiagnostics will accelerate progress in human aging research.
Related Concept Videos
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:16Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:20Study Designs in Epidemiology
266
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
266
01:29Bias in Epidemiological Studies
352
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
352
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147